These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16792686)

  • 1. Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.
    Léonard S; Pierard I; Michaelsen TE; Izui S; Masson PL; Coutelier JP
    Clin Exp Immunol; 2006 Jul; 145(1):155-61. PubMed ID: 16792686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
    Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
    Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R; Lemieux R; Tremblay T; St-Amour I
    Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized Mice.
    Schwab I; Lux A; Nimmerjahn F
    Cell Rep; 2015 Oct; 13(3):610-620. PubMed ID: 26456831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective isotype-specific regulation of IgA anti-erythrocyte autoantibody-forming cells in NZB mice.
    Moore JS; Hoover RG
    J Immunol; 1989 Jun; 142(12):4282-8. PubMed ID: 2786026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation of macrophage cytolytic and phagocytic activities by antibodies of different classes and class-specific Fc-receptors.
    Walker WS
    J Immunol; 1977 Aug; 119(2):367-73. PubMed ID: 886183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of N-acetyl-beta-D-galactosamine-specific lectin to Fc receptor-mediated phagocytosis by mouse peritoneal macrophages.
    Aramaki Y; Murai M; Tsuchiya S
    Immunology; 1993 Jul; 79(3):403-7. PubMed ID: 8406569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Fc receptor-mediated phagocytosis by mouse peritoneal macrophages following the intraperitoneal administration of liposomes.
    Aramaki Y; Murai M; Tsuchiya S
    Pharm Res; 1994 Apr; 11(4):518-21. PubMed ID: 8058608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D; Waterman SA; Gordon TP
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Fc-mediated phagocytosis in C3H/HeJ macrophages. II. Correction by cAMP agonists.
    Vogel SN; Weedon LL; Oppenheim JJ; Rosenstreich DL
    J Immunol; 1981 Feb; 126(2):441-5. PubMed ID: 6256439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions.
    Sung SS
    J Immunol; 1985 Sep; 135(3):1981-6. PubMed ID: 4020136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations.
    Gleicher N; Harlow L
    Mt Sinai J Med; 1990 Sep; 57(4):242-8. PubMed ID: 2123297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.
    Hoemberg M; Stahl D; Schlenke P; Sibrowski W; Pachmann U; Cassens U
    Scand J Immunol; 2011 Nov; 74(5):489-95. PubMed ID: 21790706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiinflammatory activity of IgG: the intravenous IgG paradox.
    Nimmerjahn F; Ravetch JV
    J Exp Med; 2007 Jan; 204(1):11-5. PubMed ID: 17227911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
    Hazenbos WL; Heijnen IA; Meyer D; Hofhuis FM; Renardel de Lavalette CR; Schmidt RE; Capel PJ; van de Winkel JG; Gessner JE; van den Berg TK; Verbeek JS
    J Immunol; 1998 Sep; 161(6):3026-32. PubMed ID: 9743367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Fc-receptor expression and Fc-mediated phagocytosis in variants of a macrophage-like cell line.
    Schneck J; Rosen OM; Diamond B; Bloom BR
    J Immunol; 1981 Feb; 126(2):745-9. PubMed ID: 6256444
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Ashkenazi L; Milner Y; Frusic-Zlotkin M; Anhalt GJ; David M; Shoenfeld Y
    Clin Exp Immunol; 2005 Dec; 142(3):426-32. PubMed ID: 16297153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.